跳至主要内容
临床试验/JPRN-UMIN000001997
JPRN-UMIN000001997已完成未知

Effects of pioglitazone or metformin on bone markers and bone mineral density as well as parameters of atherosclerosis in patients with type 2 diabetes - Effects of pioglitazone or metformin on bone metabolism and atherosclerosis

Department of Internal Medicine 1, Shimane University School of Medicine0 个研究点目标入组 60 人开始时间: 2009年5月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

In the pioglitazone group bone mineral density at femoral neck and radius were significantly decreased, whereas the parameters of atherosclerosis were not changed. On the other hand, in the metformin group bone mineral density was not changed, whereas the parameters of atherosclerosis were significantly increased.

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Nobody had hepatic or renal dysfunction or nutritional derangements. Patients treated with TZDs and metformin were excluded from this study. All patients were free of drugs known to influence bone and calcium metabolism, such as vitamin D, bisphosphonate, or estrogen, up until the time of the study.

研究者

发起方
Department of Internal Medicine 1, Shimane University School of Medicine

相似试验